395 related articles for article (PubMed ID: 30354268)
21. Ultrasound features of highly vascularized uterine myomas (uterine smooth muscle tumors) and correlation with histopathology.
Russo C; Camilli S; Martire FG; Di Giovanni A; Lazzeri L; Malzoni M; Zupi E; Exacoustos C
Ultrasound Obstet Gynecol; 2022 Aug; 60(2):269-276. PubMed ID: 35018681
[TBL] [Abstract][Full Text] [Related]
22. Leiomyosarcoma uteri in a white woman.
Adesiyun AG; Samaila MO
Ann Afr Med; 2010; 9(1):35-8. PubMed ID: 20418648
[TBL] [Abstract][Full Text] [Related]
23. Differentiating leiomyosarcoma from leiomyoma: in support of an MR imaging predictive scoring system.
Jagannathan JP; Steiner A; Bay C; Eisenhauer E; Muto MG; George S; Fennessy FM
Abdom Radiol (NY); 2021 Oct; 46(10):4927-4935. PubMed ID: 34075468
[TBL] [Abstract][Full Text] [Related]
24. Preoperative evaluation in women with uterine leiomyosarcoma. A nationwide cohort study.
Skorstad M; Kent A; Lieng M
Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1228-1234. PubMed ID: 27564388
[TBL] [Abstract][Full Text] [Related]
25. MR imaging of atypical fibroids.
Bolan C; Caserta MP
Abdom Radiol (NY); 2016 Dec; 41(12):2332-2349. PubMed ID: 27826698
[TBL] [Abstract][Full Text] [Related]
26. Leiomyosarcoma arising in a patient with prior mitotically active leiomyoma.
Kim JH; Choi YJ; Kim DC; Lee SJ
J Obstet Gynaecol Res; 2010 Feb; 36(1):187-90. PubMed ID: 20178549
[TBL] [Abstract][Full Text] [Related]
27. U.S. Food and Drug Administration's Guidance Regarding Morcellation of Leiomyomas: Well-Intentioned, But Is It Harmful for Women?
Parker WH; Kaunitz AM; Pritts EA; Olive DL; Chalas E; Clarke-Pearson DL; Berek JS;
Obstet Gynecol; 2016 Jan; 127(1):18-22. PubMed ID: 26646134
[TBL] [Abstract][Full Text] [Related]
28. Incidence of occult leiomyosarcoma in presumed morcellation cases: a database study.
Rodriguez AM; Zeybek B; Asoglu MR; Sak ME; Tan A; Borahay MA; Kilic GS
Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():31-5. PubMed ID: 26699101
[TBL] [Abstract][Full Text] [Related]
29. A Multicentre Retrospective Review of Clinical Characteristics of Uterine Sarcoma.
Wais M; Tepperman E; Bernardini MQ; Gien LT; Jimenez W; Murji A
J Obstet Gynaecol Can; 2017 Aug; 39(8):652-658. PubMed ID: 28729098
[TBL] [Abstract][Full Text] [Related]
30. Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma.
Parker WH; Fu YS; Berek JS
Obstet Gynecol; 1994 Mar; 83(3):414-8. PubMed ID: 8127535
[TBL] [Abstract][Full Text] [Related]
31. MRI Evaluation of Uterine Masses for Risk of Leiomyosarcoma: A Consensus Statement.
Hindman N; Kang S; Fournier L; Lakhman Y; Nougaret S; Reinhold C; Sadowski E; Huang JQ; Ascher S
Radiology; 2023 Feb; 306(2):e211658. PubMed ID: 36194109
[TBL] [Abstract][Full Text] [Related]
32. Inefficiency of ulipristal acetate on uterus leiomyomas as an additional sign to suspect leiomyosarcoma.
Kadhel P; Smail M; Borja De Mozota D
J Gynecol Obstet Hum Reprod; 2017 Sep; 46(7):609-611. PubMed ID: 28647614
[TBL] [Abstract][Full Text] [Related]
33. Uterine sarcomas versus leiomyomas: gray-scale and Doppler sonographic findings.
Aviram R; Ochshorn Y; Markovitch O; Fishman A; Cohen I; Altaras MM; Tepper R
J Clin Ultrasound; 2005 Jan; 33(1):10-3. PubMed ID: 15690441
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the diagnostic accuracy of contrast-enhanced MRI and diffusion-weighted MRI in the differentiation between uterine leiomyosarcoma / smooth muscle tumor with uncertain malignant potential and benign leiomyoma.
Lin G; Yang LY; Huang YT; Ng KK; Ng SH; Ueng SH; Chao A; Yen TC; Chang TC; Lai CH
J Magn Reson Imaging; 2016 Feb; 43(2):333-42. PubMed ID: 26383110
[TBL] [Abstract][Full Text] [Related]
35. PREOPERATIVE MAGNETIC RESONANCE IMAGING DIAGNOSTIC FEATURES OF UTERINE LEIOMYOSARCOMAS: A SYSTEMATIC REVIEW.
Kaganov H; Ades A; Fraser DS
Int J Technol Assess Health Care; 2018 Jan; 34(2):172-179. PubMed ID: 29642961
[TBL] [Abstract][Full Text] [Related]
36. What MRI features suspect malignant pure mesenchymal uterine tumors rather than uterine leiomyoma with cystic degeneration?
Kim TH; Kim JW; Kim SY; Kim SH; Cho JY
J Gynecol Oncol; 2018 May; 29(3):e26. PubMed ID: 29400019
[TBL] [Abstract][Full Text] [Related]
37. The management of uterine leiomyomas.
Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
[TBL] [Abstract][Full Text] [Related]
38. The differential diagnoses of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing.
Mas A; Alonso R; Garrido-Gómez T; Escorcia P; Montero B; Jiménez-Almazán J; Martín J; Pellicer N; Monleón J; Simón C
Am J Obstet Gynecol; 2019 Oct; 221(4):320.e1-320.e23. PubMed ID: 31121144
[TBL] [Abstract][Full Text] [Related]
39. Uterine fibroid-like tumors: spectrum of MR imaging findings and their differential diagnosis.
Lin Y; Wu RC; Huang YL; Chen K; Tseng SC; Wang CJ; Chao A; Lai CH; Lin G
Abdom Radiol (NY); 2022 Jun; 47(6):2197-2208. PubMed ID: 35347386
[TBL] [Abstract][Full Text] [Related]
40. Leiomyosarcoma after uterine artery embolization. A case report.
Joyce A; Hessami S; Heller D
J Reprod Med; 2001 Mar; 46(3):278-80. PubMed ID: 11304875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
